A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclero (Q35168612)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclero	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclero (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Bianca Weinstock-Guttman

10

object named as

Bianca Weinstock-Guttman

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Silva Markovic-Plese

3

object named as

Silva Markovic-Plese

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Robert Zivadinov

1

object named as

Robert Zivadinov

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

author name string

Michael Dwyer

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Brooke Hayward

4

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Niels Bergsland

5

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Mari Heininen-Brown

6

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Ellen Carl

7

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Cheryl Kennedy

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Fernando Dangond

9

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

publication date

1 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Therapeutic advances in neurological disorders

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

59-70

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

28 July 2018

Quantitative susceptibility mapping of multiple sclerosis lesions at various ages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

28 July 2018

Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

28 July 2018

Biophysical mechanisms of MRI signal frequency contrast in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

28 July 2018

Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

28 July 2018

Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

28 July 2018

Chronic multiple sclerosis lesions: characterization with high-field-strength MR imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

28 July 2018

Susceptibility induced gray-white matter MRI contrast in the human brain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

28 July 2018

Advances in metal-induced oxidative stress and human disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

28 July 2018

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

28 July 2018

A Bayesian model of shape and appearance for subcortical brain segmentation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

28 July 2018

Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

28 July 2018

A global optimisation method for robust affine registration of brain images

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

28 July 2018

Phase white matter signal abnormalities in patients with clinically isolated syndrome and other neurologic disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Gray matter SWI-filtered phase and atrophy are linked to disability in MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Brain iron accumulation in aging and neurodegenerative disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Iron content of the pulvinar nucleus of the thalamus is increased in adolescent multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

A serial in vivo 7T magnetic resonance phase imaging study of white matter lesions in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Iron deposition in multiple sclerosis lesions measured by susceptibility-weighted imaging filtered phase: a case control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis: a case-control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Detecting lesions in multiple sclerosis at 4.7 tesla using phase susceptibility-weighting and T2-weighting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Characterizing iron deposition in multiple sclerosis lesions using susceptibility weighted imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Is stored iron safe?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Susceptibility weighted imaging (SWI).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

The effect of age on the non-haemin iron in the human brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Iron deposits in multiple sclerosis and Alzheimer's disease brains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4356661

27 September 2018

Brain ferritin iron may influence age- and gender-related risks of neurodegeneration

1 reference

https://api.crossref.org/works/10.1177%2F1756285615572953

21 January 2018

Iron deposition on SWI-filtered phase in the subcortical deep gray matter of patients with clinically isolated syndrome may precede structure-specific atrophy

1 reference

https://api.crossref.org/works/10.1177%2F1756285615572953

21 January 2018

Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1756285615572953

21 January 2018

Impact of tissue atrophy on high-pass filtered MRI signal phase-based assessment in large-scale group-comparison studies: a simulation study

1 reference

https://api.crossref.org/works/10.1177%2F1756285615572953

21 January 2018

Identifiers

10.1177/1756285615572953

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35168612&oldid=1819833112"